Company Overview and News
The spate of cyberattacks in the past years has prompted major tech firms to sign a pact to work together, and to agree not to help governments launch offensive measures against innocent parties. Image: Damien Meyer/AFP
Thirty-four global technology companies and organizations signed a pact Tuesday calling for a stronger defense against cyberattacks in any form and pledging to refrain from helping governments attack "innocent" civilians or enterprises.
SAN FRANCISCO: Thirty-four global technology companies and organisations signed a pact on Tuesday (Apr 17) calling for a stronger defence against cyberattacks in any form and pledging to refrain from helping governments attack "innocent" civilians or enterprises.
SAN FRANCISCO: Microsoft, Facebook and more than 30 other global technology companies on Tuesday announced a joint pledge not to assist any government in offensive cyber attacks.
SAN FRANCISCO (Reuters) - Microsoft, Facebook and more than 30 other global technology companies on Tuesday announced a joint pledge not to assist any government in offensive cyber attacks.
Amazon.com, Inc.’s (AMZN - Free Report) subsidiary Amazon Web Services (“AWS”) recently launched a storage service called Amazon S3 Z-IA, which combines the beneficial features of Amazon S3 with the facility of one zone-infrequent access (Z-IA). The new service will allow users to store their infrequently accessed data into a single availability zone instead of multiple zones of AWS that S3 Standard-IA provides.
Tumult in FAANG stocks is now probably the hottest topic of discussion in the investment world. The issue started with the rout in the Facebook Inc (NASDAQ:FB) stock on Mar 19 on reports of data breaches, but finally spread into the other areas of the tech space.
Tumult in FAANG stocks is now probably the hottest topic of discussion in the investment world. The issue started with the rout in the Facebook (FB - Free Report) stock on Mar 19 on reports of data breaches, but finally spread into the other areas of the tech space (read: 5 Reason Why FANG ETFs Lost Their Charm in March).
The past couple of years have been transformational for Symantec (NASDAQ:SYMC) with two divestitures, several acquisitions, and new leadership. It has now refocused itself exclusively on cyber security and has undertaken several measures to reduce complexity and costs.
SINGAPORE: Technology, which have been identified as a key contributor to the speed and scale of how false information is spread, can also help to counter the threat, according to experts from IT security company Trend Micro.
Australia's new data breach laws require businesses and government entities to disclose hacks and leaks that cause "serious harm", with fines of up to $2.1 million for those who don't comply, but experts say the agency responsible for enforcing them may not have the resources to do so.
North Korea is one of the least wired nations on Earth. It has two internet connections to the outside world, one that crosses the Yalu River into China, and the other plugs into Russia's Far East.
WASHINGTON/MOSCOW (Reuters) - Major global technology providers SAP (SAPG.DE), Symantec (SYMC.O) and McAfee have allowed Russian authorities to hunt for vulnerabilities in software deeply embedded across the U.S. government, a Reuters investigation has found.
2018-04-18 - Asif
History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...
2018-04-16 - Asif
Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...
2018-04-16 - Asif
Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...
2018-04-15 - Asif
Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...
2018-04-12 - Asif
Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...
as of ET